Antiviral phosphinate compounds
US8586744B2 · kind B2 · utility
0Cited by
8References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2010 |
| Grant date | Nov 19, 2013 |
| Priority date | — |
| Expiry date | Dec 18, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is related to a method of treating disorders associated with hepatitis C by administering to an individual a pharmaceutical composition which comprises a therapeutically effective amount of an anti-viral phosphinate compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.